EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.23.20 | Carcinoma |
23105293 |
Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
3
0 |
| 3.4.23.20 | Cystinuria |
641953 |
Erythropoietic protoporphyria, heterozygous cystinuria, and reduced peptidase A activity in a patient with 46,XX/46,XX,18q--mosaicism. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
2
1
0 |
| 3.4.23.20 | Hepatitis C |
19281487 |
Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. |
causal interaction
ongoing research
unassigned |
2
3
0 |
| 3.4.23.20 | Mitochondrial Diseases |
30885675 |
Controlling proteolysis of Clp peptidase: a possible target for combating mitochondrial diseases. |
unassigned |
0 |
| 3.4.23.20 | Neoplasm Metastasis |
32174187 |
Exploring the structural aspects of ureido-amino acid-based APN inhibitors: a validated comparative multi-QSAR modelling study. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 3.4.23.20 | Neoplasms |
28659922 |
A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFN?-Producing CD8(+) T Cells Essential for the Protection against Experimental Visceral Leishmaniasis. |
ongoing research
unassigned |
3
0 |
| 3.4.23.20 | Neoplasms |
32174187 |
Exploring the structural aspects of ureido-amino acid-based APN inhibitors: a validated comparative multi-QSAR modelling study. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 3.4.23.20 | Protoporphyria, Erythropoietic |
641953 |
Erythropoietic protoporphyria, heterozygous cystinuria, and reduced peptidase A activity in a patient with 46,XX/46,XX,18q--mosaicism. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
2
1
0 |
| 3.4.23.20 | Sarcoma |
1892247 |
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH). |
ongoing research
unassigned |
2
0 |
| 3.4.23.20 | Trisomy 18 Syndrome |
3052940 |
Fibroblasts of two patients with trisomy 18 show 1.5-fold increase in peptidase A activity over normal human diploid fibroblasts. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
